Screener
PTC Therapeutics PTCT Cash Flow Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| -$51.69M-425% | $83.5M+229% | -$2.81M-100% | —— | $15.9M+115% | ||
| $16.82M+51.4% | $15.87M+109% | $15.41M+113% | $12.9M+90.7% | $11.11M+71.3% | ||
| $23.83M+22.7% | $23.29M+25.6% | $23.42M+29.7% | $18.52M+7.4% | $19.43M-1.7% | ||
| —— | $129.11M— | -$59.04M-107% | —— | —— | ||
| $2.66M-22.9% | $2.19M+66.4% | $1.2M-30.6% | $2.37M-37.0% | $3.45M+560% | ||
| -$442.41M-52.8% | -$122.56M+71.0% | -$93.74M+49.2% | $0-100% | -$289.62M-579% | ||
| —— | $211.88M+5,249% | $6.4M-32.0% | $302.5M+1,043% | $15.22M— | ||
| -$541M-56.0% | $215.9M— | -$147.9M-121% | $312.03M+22.1% | -$346.77M-169% |
FAQ
- Where does PTC Therapeutics's cash flow data come from?
- Every line is extracted from PTC Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
